Brinker Capital Investments’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Brinker Capital Investments’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,260	Closed	-$1.26M	–	1955
2026 Q1	$1.26M	Buy	6,260 +244	+4%	+$50.5K	0.01%	984
2025 Q4	$1.24M	Buy	6,016 +637	+12%	+$127K	0.01%	1123
2025 Q3	$964K	Sell	5,379 -3	-0.1%	-$511	0.01%	1254
2025 Q2	$868K	Sell	5,382 -13,101	-71%	-$2.09M	0.01%	1259
2025 Q1	$1.66M	Buy	18,483 +12,991	+237%	+$2.26M	0.02%	807
2024 Q4	$913K	Buy	5,492 +185	+3%	+$31.6K	0.01%	1105
2024 Q3	$912K	Buy	+5,307	New	+$878K	0.01%	1090
2019 Q3	–	Sell	-463	Closed	-$65K	–	818
2019 Q2	$65K	Buy	463 +237	+105%	+$32.7K	﹤0.01%	560
2019 Q1	$34K	Buy	+226	New	+$32.5K	﹤0.01%	506
2016 Q4	–	Sell	-45	Closed	-$4K	–	537
2016 Q3	$4K	Hold	45	–	–	﹤0.01%	425
2016 Q2	$4K	Buy	+45	New	+$4.13K	﹤0.01%	359

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Brinker Capital Investments's FBT Position: Q2 2026 in Review

Brinker Capital Investments sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026, closing a stake of 6,260 shares — an estimated $1.26M sold.

Brinker Capital Investments first reported a position in FBT in Q2 2016 and held it in 11 quarters. The position peaked at $1.66M in Q1 2025. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Brinker Capital Investments reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2026 after selling out during the quarter.
Brinker Capital Investments sold 6,260 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $1.26M.
Brinker Capital Investments first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2016 and held it in 11 quarters.
Brinker Capital Investments's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.66M in Q1 2025.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.